Apr 27: Following reports that Israeli Prime Minister Benjamin Netanyahu received radiation therapy for early-stage prostate cancer, experts from the American Society for Radiation Oncology (ASTRO) are available to discuss the science behind this approach and what it means for the many men diagnosed with prostate cancer each year.
Prostate cancer is one of the most common cancers, and when detected early, patients and their physicians often face a meaningful choice among radiation therapy, active surveillance and surgery. Radiation therapy is a well-established, evidence-supported option for early-stage disease that offers a high likelihood of cure while preserving quality of life.
ASTRO experts can provide context on:
-
What early-stage versus higher-risk disease means for treatment planning
-
How radiation therapy works as a treatment for early-stage prostate cancer
-
How physicians and patients weigh radiation against other options, including active surveillance and surgery
-
Advances in treatment precision that reduce side effects and increase patient convenience
-
Questions patients should bring to their care team
Experts are available for background or interviews to provide clear, evidence-based information for patients and the public.
